Component
Tetrahydrobiopterin / BH4
Tetrahydrobiopterin / BH4. Species, exposure and limitations are retained in each linked claim.
32 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Human pineal TPH activity was measured with BH4, and a transient 4alpha-hydroxytetrahydrobiopterin intermediate was detected.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/10525150.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f", "start_char": 0, "end_char": 1489, "text_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f"}
- experimental_model
- Recombinant enzyme purification and catalysis
- exposure
- L-tryptophan with tetrahydrobiopterin; purified tetrameric enzyme
- limitations
- TPH1 and neuronal TPH2 are distinct. A cofactor-dependent reaction does not prove supplemental cofactor increases melatonin in a replete person.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human pineal TPH1 expressed in E. coli
- plain_language
- The pterin cofactor participates chemically; it is not interchangeable with folate.
- primary_references
- [melatonin-p10525150] Cloning and expression of recombinant human pineal tryptophan hydroxylase in Escherichia coli: purification and characterization of the cloned enzyme. (1999). https://pubmed.ncbi.nlm.nih.gov/10525150/ DOI: 10.1016/s0167-4838(99)00184-3
- tissue_or_cell_type
- Tryptophan hydroxylation
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 149–160
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant enzyme purification and catalysis · source_derived_draft · unverified_draft
### melatonin-tph1-bh4 Human pineal TPH activity was measured with BH4, and a transient 4alpha-hydroxytetrahydrobiopterin intermediate was detected. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The pterin cofactor participates chemically; it is not interchangeable with folate. organism: Human pineal TPH1 expressed in E. coli tissue_or_cell_type: Tryptophan hydroxylation experimental_model: Recombinant enzyme purification and catalysis limitations: TPH1 and neuronal TPH2 are distinct. A cofactor-dependent reaction does not prove supplemental cofactor increases melatonin in a replete person. exposure: L-tryptophan with tetrahydrobiopterin; purified tetrameric enzyme evidence_span: {"source_cache": "artifacts/melatonin-research/10525150.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f", "start_char": 0, "end_char": 1489, "text_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f"} [melatonin-p10525150] Cloning and expression of recombinant human pineal tryptophan hydroxylase in Escherichia coli: purification and characterization of the cloned enzyme. (1999). https://pubmed.ncbi.nlm.nih.gov/10525150/ DOI: 10.1016/s0167-4838(99)00184-3
Complete structured claim and evidenceBH4 and phenylalanine favored inhibited and activated human GCH1-GFRP complexes, respectively; ligand-dependent conformational changes stabilized binding.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human purified proteins, crystallography and binding/kinetic studies.
- limitations
- Cofactor synthesis has additional steps; structural regulation does not establish a clinical depletion or supplementation effect.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- Cofactor production has both a demand signal and a feedback brake.
- primary_references
- Biophysical and structural investigation of the regulation of human GTP cyclohydrolase I by its regulatory protein GFRP. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33387654/ · DOI 10.1016/j.jsb.2020.107691
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 46–52
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human purified proteins, crystallography and binding/kinetic studies. · source_derived_draft · unverified_draft
## l-phenylalanine-gch1-feedback Cofactor production has both a demand signal and a feedback brake. BH4 and phenylalanine favored inhibited and activated human GCH1-GFRP complexes, respectively; ligand-dependent conformational changes stabilized binding. Model: Human purified proteins, crystallography and binding/kinetic studies. Limitations: Cofactor synthesis has additional steps; structural regulation does not establish a clinical depletion or supplementation effect. Evidence access: Primary abstract Biophysical and structural investigation of the regulation of human GTP cyclohydrolase I by its regulatory protein GFRP. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33387654/ · DOI 10.1016/j.jsb.2020.107691
Complete structured claim and evidenceRecombinant human TH1 bound natural BH4 with negative cooperativity; Ser40 phosphorylation increased apparent BH4 affinity.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human TH1 kinetics and surface plasmon resonance; PKA phosphorylation.
- limitations
- These kinetic values are not blood targets or instructions to supplement BH4.
- nutrient_topic
- L-Tyrosine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Tyrosine
- plain_language
- The cofactor response changes with enzyme regulation.
- primary_references
- Tyrosine hydroxylase binds tetrahydrobiopterin cofactor with negative cooperativity, as shown by kinetic analyses and surface plasmon resonance detection. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10411647/ · DOI 10.1046/j.1432-1327.1999.00445.x
L-Tyrosine: catecholamines, thyroid chemistry, pigment, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 28–34
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human TH1 kinetics and surface plasmon resonance; PKA phosphorylation. · source_derived_draft · unverified_draft
## l-tyrosine-th-cofactor-regulation The cofactor response changes with enzyme regulation. Recombinant human TH1 bound natural BH4 with negative cooperativity; Ser40 phosphorylation increased apparent BH4 affinity. Model: Human TH1 kinetics and surface plasmon resonance; PKA phosphorylation. Limitations: These kinetic values are not blood targets or instructions to supplement BH4. Evidence access: Primary abstract Tyrosine hydroxylase binds tetrahydrobiopterin cofactor with negative cooperativity, as shown by kinetic analyses and surface plasmon resonance detection. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10411647/ · DOI 10.1046/j.1432-1327.1999.00445.x
Complete structured claim and evidencePurified human eNOS showed an absolute BH4 requirement for the measured catalytic reaction.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10608822.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd", "start_char": 0, "end_char": 2100, "text_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd"}
- experimental_model
- Purified recombinant enzyme activity and cofactor analysis
- exposure
- Arginine substrate; BH4, FAD, FMN, heme, iron and zinc measurements
- limitations
- Biochemical cofactor findings do not show that extra dietary cofactors increase NO in healthy people.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human NOS3 expressed in yeast
- plain_language
- Supplying substrate does not replace the required pterin cofactor.
- primary_references
- [citrulline-p10608822] Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris. (1999). https://pubmed.ncbi.nlm.nih.gov/10608822/ DOI: 10.1074/jbc.274.53.37658
- tissue_or_cell_type
- Endothelial NOS enzyme preparation
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 515–526
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified recombinant enzyme activity and cofactor analysis · source_derived_draft · unverified_draft
### citrulline-nos-bh4 Purified human eNOS showed an absolute BH4 requirement for the measured catalytic reaction. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Supplying substrate does not replace the required pterin cofactor. organism: Human NOS3 expressed in yeast tissue_or_cell_type: Endothelial NOS enzyme preparation experimental_model: Purified recombinant enzyme activity and cofactor analysis limitations: Biochemical cofactor findings do not show that extra dietary cofactors increase NO in healthy people. exposure: Arginine substrate; BH4, FAD, FMN, heme, iron and zinc measurements evidence_span: {"source_cache": "artifacts/citrulline-research/10608822.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd", "start_char": 0, "end_char": 2100, "text_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd"} [citrulline-p10608822] Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris. (1999). https://pubmed.ncbi.nlm.nih.gov/10608822/ DOI: 10.1074/jbc.274.53.37658
Complete structured claim and evidenceBH4 plus arginine shifted human eNOS toward dimers during low-temperature electrophoresis.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10608822.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd", "start_char": 0, "end_char": 2100, "text_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd"}
- experimental_model
- Purified recombinant enzyme activity and cofactor analysis
- exposure
- Arginine substrate; BH4, FAD, FMN, heme, iron and zinc measurements
- limitations
- Biochemical cofactor findings do not show that extra dietary cofactors increase NO in healthy people.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human NOS3 expressed in yeast
- plain_language
- Cofactor and substrate helped stabilize the paired enzyme structure.
- primary_references
- [citrulline-p10608822] Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris. (1999). https://pubmed.ncbi.nlm.nih.gov/10608822/ DOI: 10.1074/jbc.274.53.37658
- tissue_or_cell_type
- Endothelial NOS enzyme preparation
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 580–591
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified recombinant enzyme activity and cofactor analysis · source_derived_draft · unverified_draft
### citrulline-nos-dimer BH4 plus arginine shifted human eNOS toward dimers during low-temperature electrophoresis. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Cofactor and substrate helped stabilize the paired enzyme structure. organism: Human NOS3 expressed in yeast tissue_or_cell_type: Endothelial NOS enzyme preparation experimental_model: Purified recombinant enzyme activity and cofactor analysis limitations: Biochemical cofactor findings do not show that extra dietary cofactors increase NO in healthy people. exposure: Arginine substrate; BH4, FAD, FMN, heme, iron and zinc measurements evidence_span: {"source_cache": "artifacts/citrulline-research/10608822.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd", "start_char": 0, "end_char": 2100, "text_sha256": "1600b193cc63f30b204285729710bb81f34bc2918a8ca7f97aa97bc4acd998fd"} [citrulline-p10608822] Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris. (1999). https://pubmed.ncbi.nlm.nih.gov/10608822/ DOI: 10.1074/jbc.274.53.37658
Complete structured claim and evidenceAscorbate had no additional effect at high BH4 or after sepiapterin raised cellular BH4.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"}
- experimental_model
- Cell exposure and recombinant-enzyme assays
- exposure
- Ascorbate loading; BH4 or sepiapterin comparisons
- limitations
- Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Porcine aortic endothelial cells and bovine eNOS
- plain_language
- The benefit depended on the starting cofactor conditions.
- primary_references
- [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
- tissue_or_cell_type
- BH4 availability and NO bioactivity
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 723–734
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell exposure and recombinant-enzyme assays · source_derived_draft · unverified_draft
### citrulline-vitaminc-bh4-saturation Ascorbate had no additional effect at high BH4 or after sepiapterin raised cellular BH4. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The benefit depended on the starting cofactor conditions. organism: Porcine aortic endothelial cells and bovine eNOS tissue_or_cell_type: BH4 availability and NO bioactivity experimental_model: Cell exposure and recombinant-enzyme assays limitations: Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline. exposure: Ascorbate loading; BH4 or sepiapterin comparisons evidence_span: {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"} [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
Complete structured claim and evidenceThe pterin binds in the active-site cleft forming an aromatic stacking interaction with Phe300, which is itself hydroxylated in the meta position by an autocatalytic process and anchored by a hydrogen bond to the carbonyl of Gln310; the iron sits 5.6 angstrom from the pterin 4a carbon, and molecular oxygen could bind in a bridging position between the pterin and the iron before substrate hydroxylation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/cold-research/9753429.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9", "start_char": 0, "end_char": 1695, "text_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9"}
- experimental_model
- Crystal structure of rat tyrosine hydroxylase with a cofactor analogue and iron at 2.3 angstrom
- exposure
- Bound 7,8-dihydrobiopterin and iron
- limitations
- Structural chemistry of the rate-limiting step. It is a rat enzyme structure with a cofactor analogue, not a measurement of iron status in an animal.
- nutrient_topic
- Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. · Cold water immersion
- organism
- Rat enzyme
- plain_language
- The oxygen molecule slots into the gap between the cofactor and the iron.
- primary_references
- [cold-p9753429] Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site. (1998). https://pubmed.ncbi.nlm.nih.gov/9753429/ DOI: 10.1021/bi981462g
- tissue_or_cell_type
- Purified catalytic and tetramerization domains
Cold water immersion: cold sensing, heat production, the catecholamine axis and what repeated exposure changes (2026-09-19) · lines 546–557
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crystal structure of rat tyrosine hydroxylase with a cofactor analogue and iron at 2.3 angstrom · source_derived_draft · unverified_draft
### cold-th-pterin-geometry The pterin binds in the active-site cleft forming an aromatic stacking interaction with Phe300, which is itself hydroxylated in the meta position by an autocatalytic process and anchored by a hydrogen bond to the carbonyl of Gln310; the iron sits 5.6 angstrom from the pterin 4a carbon, and molecular oxygen could bind in a bridging position between the pterin and the iron before substrate hydroxylation. Condition category: normal nutrient_topic: Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. plain_language: The oxygen molecule slots into the gap between the cofactor and the iron. organism: Rat enzyme tissue_or_cell_type: Purified catalytic and tetramerization domains experimental_model: Crystal structure of rat tyrosine hydroxylase with a cofactor analogue and iron at 2.3 angstrom limitations: Structural chemistry of the rate-limiting step. It is a rat enzyme structure with a cofactor analogue, not a measurement of iron status in an animal. exposure: Bound 7,8-dihydrobiopterin and iron evidence_span: {"source_cache": "artifacts/cold-research/9753429.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9", "start_char": 0, "end_char": 1695, "text_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9"} [cold-p9753429] Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site. (1998). https://pubmed.ncbi.nlm.nih.gov/9753429/ DOI: 10.1021/bi981462g
Complete structured claim and evidenceBH4 stimulated both partial reactions; the first increased approximately threefold.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat cerebellar NOS preparation; separated partial reactions.
- limitations
- Assay-specific stimulation, not a dietary BH4 or arginine treatment rule.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- Substrate availability and cofactor availability are separate requirements.
- primary_references
- Characteristics of the nitric oxide synthase-catalyzed conversion of arginine to N-hydroxyarginine, the first oxygenation step in the enzymic synthesis of nitric oxide. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7530247/ · DOI 10.1074/jbc.270.4.1721
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 86–92
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Rat cerebellar NOS preparation; separated partial reactions. · source_derived_draft · unverified_draft
## arg-nos-bh4 Substrate availability and cofactor availability are separate requirements. BH4 stimulated both partial reactions; the first increased approximately threefold. Model: Rat cerebellar NOS preparation; separated partial reactions. Limitations: Assay-specific stimulation, not a dietary BH4 or arginine treatment rule. Evidence access: Primary abstract Characteristics of the nitric oxide synthase-catalyzed conversion of arginine to N-hydroxyarginine, the first oxygenation step in the enzymic synthesis of nitric oxide. · 1995 · https://pubmed.ncbi.nlm.nih.gov/7530247/ · DOI 10.1074/jbc.270.4.1721
Complete structured claim and evidence
What acts on it
PCBD1 has a pterin-carbinolamine dehydratase role in BH4 regeneration; biallelic defects are associated with transient neonatal hyperphenylalaninemia and primapterinuria.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human PCBD1 mutation study; established biochemical role and disease background.
- limitations
- The renal study does not directly measure whole-body BH4 recycling flux. The transcriptional role below is separately recorded.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- One cofactor-recycling protein has another important job in the kidney.
- primary_references
- Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24204001/ · DOI 10.1681/ASN.2013040337
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 62–68
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human PCBD1 mutation study; established biochemical role and disease background. · source_derived_draft · unverified_draft
## l-phenylalanine-pcbd-recycling-role One cofactor-recycling protein has another important job in the kidney. PCBD1 has a pterin-carbinolamine dehydratase role in BH4 regeneration; biallelic defects are associated with transient neonatal hyperphenylalaninemia and primapterinuria. Model: Human PCBD1 mutation study; established biochemical role and disease background. Limitations: The renal study does not directly measure whole-body BH4 recycling flux. The transcriptional role below is separately recorded. Evidence access: Primary abstract Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24204001/ · DOI 10.1681/ASN.2013040337
Complete structured claim and evidence
Where it participates (unsigned role)
Purified human pineal TPH catalyzed tryptophan hydroxylation to 5-hydroxytryptophan.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/10525150.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f", "start_char": 0, "end_char": 1489, "text_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f"}
- experimental_model
- Recombinant enzyme purification and catalysis
- exposure
- L-tryptophan with tetrahydrobiopterin; purified tetrameric enzyme
- limitations
- TPH1 and neuronal TPH2 are distinct. A cofactor-dependent reaction does not prove supplemental cofactor increases melatonin in a replete person.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human pineal TPH1 expressed in E. coli
- plain_language
- The amino acid tryptophan must pass through an enzyme-controlled first step.
- primary_references
- [melatonin-p10525150] Cloning and expression of recombinant human pineal tryptophan hydroxylase in Escherichia coli: purification and characterization of the cloned enzyme. (1999). https://pubmed.ncbi.nlm.nih.gov/10525150/ DOI: 10.1016/s0167-4838(99)00184-3
- tissue_or_cell_type
- Tryptophan hydroxylation
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 136–147
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant enzyme purification and catalysis · source_derived_draft · unverified_draft
### melatonin-tph1-hydroxylation Purified human pineal TPH catalyzed tryptophan hydroxylation to 5-hydroxytryptophan. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The amino acid tryptophan must pass through an enzyme-controlled first step. organism: Human pineal TPH1 expressed in E. coli tissue_or_cell_type: Tryptophan hydroxylation experimental_model: Recombinant enzyme purification and catalysis limitations: TPH1 and neuronal TPH2 are distinct. A cofactor-dependent reaction does not prove supplemental cofactor increases melatonin in a replete person. exposure: L-tryptophan with tetrahydrobiopterin; purified tetrameric enzyme evidence_span: {"source_cache": "artifacts/melatonin-research/10525150.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f", "start_char": 0, "end_char": 1489, "text_sha256": "032acfb7b1818f5282f5457e093a7e371895bbdc95f058c8958766fc57f9118f"} [melatonin-p10525150] Cloning and expression of recombinant human pineal tryptophan hydroxylase in Escherichia coli: purification and characterization of the cloned enzyme. (1999). https://pubmed.ncbi.nlm.nih.gov/10525150/ DOI: 10.1016/s0167-4838(99)00184-3
Complete structured claim and evidenceDNAJC12 interacted with aromatic amino-acid hydroxylases, including PAH, tyrosine hydroxylase and tryptophan hydroxylases.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human DNAJC12 deficiency study with functional interaction experiments.
- limitations
- Interaction does not imply identical effects in all tissues or rescue by extra substrate.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- A shared chaperone supports several amino-acid processing enzymes.
- primary_references
- Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28132689/ · DOI 10.1016/j.ajhg.2017.01.002
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 102–108
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human DNAJC12 deficiency study with functional interaction experiments. · source_derived_draft · unverified_draft
## l-phenylalanine-dnaj-chaperone A shared chaperone supports several amino-acid processing enzymes. DNAJC12 interacted with aromatic amino-acid hydroxylases, including PAH, tyrosine hydroxylase and tryptophan hydroxylases. Model: Human DNAJC12 deficiency study with functional interaction experiments. Limitations: Interaction does not imply identical effects in all tissues or rescue by extra substrate. Evidence access: Primary abstract Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28132689/ · DOI 10.1016/j.ajhg.2017.01.002
Complete structured claim and evidenceBiallelic DNAJC12 variants in six patients from four families accompanied hyperphenylalaninemia and neurotransmitter abnormalities; functional studies found reduced PAH activity.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human genetic case series and functional experiments.
- limitations
- Early combined BH4/neurotransmitter-precursor treatment was not a controlled test of phenylalanine supplementation.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- Phenylalanine can accumulate because its supporting machinery is defective.
- primary_references
- Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28132689/ · DOI 10.1016/j.ajhg.2017.01.002
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 110–116
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human genetic case series and functional experiments. · source_derived_draft · unverified_draft
## l-phenylalanine-dnaj-failure Phenylalanine can accumulate because its supporting machinery is defective. Biallelic DNAJC12 variants in six patients from four families accompanied hyperphenylalaninemia and neurotransmitter abnormalities; functional studies found reduced PAH activity. Model: Human genetic case series and functional experiments. Limitations: Early combined BH4/neurotransmitter-precursor treatment was not a controlled test of phenylalanine supplementation. Evidence access: Primary abstract Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28132689/ · DOI 10.1016/j.ajhg.2017.01.002
Complete structured claim and evidenceRecombinant human GFRP enabled phenylalanine-dependent stimulation of recombinant human GCH1.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Recombinant human proteins; primary abstract.
- limitations
- GCH1 controls an early BH4-biosynthesis step; this is not proof that supplemental phenylalanine raises BH4 in every tissue.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- The substrate can signal for more of the cofactor-making machinery to work.
- primary_references
- Bacterial lipopolysaccharide down-regulates expression of GTP cyclohydrolase I feedback regulatory protein. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11799107/ · DOI 10.1074/jbc.M107326200
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 38–44
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human proteins; primary abstract. · source_derived_draft · unverified_draft
## l-phenylalanine-gch1-feedforward The substrate can signal for more of the cofactor-making machinery to work. Recombinant human GFRP enabled phenylalanine-dependent stimulation of recombinant human GCH1. Model: Recombinant human proteins; primary abstract. Limitations: GCH1 controls an early BH4-biosynthesis step; this is not proof that supplemental phenylalanine raises BH4 in every tissue. Evidence access: Primary abstract Bacterial lipopolysaccharide down-regulates expression of GTP cyclohydrolase I feedback regulatory protein. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11799107/ · DOI 10.1074/jbc.M107326200
Complete structured claim and evidenceLPS at 1 microgram/mL reduced GFRP expression in human THP-1 cells; with interferon-gamma plus LPS, pteridine production became phenylalanine-independent.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human THP-1 cells; interferon-gamma alone compared with interferon-gamma plus LPS.
- limitations
- Pteridine output is not synonymous with bioavailable BH4; no clinical inflammatory threshold is defined.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- Inflammatory stimulation changed how this cell model responded to phenylalanine.
- primary_references
- Bacterial lipopolysaccharide down-regulates expression of GTP cyclohydrolase I feedback regulatory protein. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11799107/ · DOI 10.1074/jbc.M107326200
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 54–60
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human THP-1 cells; interferon-gamma alone compared with interferon-gamma plus LPS. · source_derived_draft · unverified_draft
## l-phenylalanine-inflammation-feedback Inflammatory stimulation changed how this cell model responded to phenylalanine. LPS at 1 microgram/mL reduced GFRP expression in human THP-1 cells; with interferon-gamma plus LPS, pteridine production became phenylalanine-independent. Model: Human THP-1 cells; interferon-gamma alone compared with interferon-gamma plus LPS. Limitations: Pteridine output is not synonymous with bioavailable BH4; no clinical inflammatory threshold is defined. Evidence access: Primary abstract Bacterial lipopolysaccharide down-regulates expression of GTP cyclohydrolase I feedback regulatory protein. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11799107/ · DOI 10.1074/jbc.M107326200
Complete structured claim and evidencePAH catalyzes phenylalanine hydroxylation to tyrosine using BH4, molecular oxygen and non-heme ferrous iron.
Experimental context and source evidence
- evidence_access
- Primary full text; reaction background distinguished from new structural experiments
- experimental_model
- Human PAH structural study; established reaction described in the full-text introduction.
- limitations
- This record describes the established reaction, not a new dietary intervention or a human iron-deficiency threshold.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- Making tyrosine requires a working enzyme and its chemical helpers.
- primary_references
- Structural basis for ligand-dependent dimerization of phenylalanine hydroxylase regulatory domain. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27049649/ · DOI 10.1038/srep23748
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 14–20
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human PAH structural study; established reaction described in the full-text introduction. · source_derived_draft · unverified_draft
## l-phenylalanine-pah-conversion Making tyrosine requires a working enzyme and its chemical helpers. PAH catalyzes phenylalanine hydroxylation to tyrosine using BH4, molecular oxygen and non-heme ferrous iron. Model: Human PAH structural study; established reaction described in the full-text introduction. Limitations: This record describes the established reaction, not a new dietary intervention or a human iron-deficiency threshold. Evidence access: Primary full text; reaction background distinguished from new structural experiments Structural basis for ligand-dependent dimerization of phenylalanine hydroxylase regulatory domain. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27049649/ · DOI 10.1038/srep23748
Complete structured claim and evidenceA catalytically characterized recombinant human dihydropteridine reductase was crystallized in complex with NADH at 2.5-angstrom resolution.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human QDPR expressed in E. coli; enzyme purification, kinetic characterization and structure.
- limitations
- This binary structure alone does not show that niacin supplementation changes phenylalanine clearance.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- The cofactor-recycling network includes an NADH-binding enzyme.
- primary_references
- The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologue. · 1993 · https://pubmed.ncbi.nlm.nih.gov/8262916/
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 70–76
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human QDPR expressed in E. coli; enzyme purification, kinetic characterization and structure. · source_derived_draft · unverified_draft
## l-phenylalanine-qdpr-nadh The cofactor-recycling network includes an NADH-binding enzyme. A catalytically characterized recombinant human dihydropteridine reductase was crystallized in complex with NADH at 2.5-angstrom resolution. Model: Human QDPR expressed in E. coli; enzyme purification, kinetic characterization and structure. Limitations: This binary structure alone does not show that niacin supplementation changes phenylalanine clearance. Evidence access: Primary abstract The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologue. · 1993 · https://pubmed.ncbi.nlm.nih.gov/8262916/
Complete structured claim and evidenceIn an 89-participant six-week PKU trial, sapropterin 10 mg/kg/day lowered mean phenylalanine by 236 micromol/L versus a 3 micromol/L rise with placebo; 44% versus 9% had at least a 30% reduction.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Randomized human PKU study enriched through prior responsiveness assessment.
- limitations
- Not all PAH defects respond; trial dose is historical evidence, not individualized guidance.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- Providing the pharmaceutical cofactor helped some patients, with substantial response variation.
- primary_references
- Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17693179/ · DOI 10.1016/S0140-6736(07)61234-3
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 222–228
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Randomized human PKU study enriched through prior responsiveness assessment. · source_derived_draft · unverified_draft
## l-phenylalanine-sapropterin-response Providing the pharmaceutical cofactor helped some patients, with substantial response variation. In an 89-participant six-week PKU trial, sapropterin 10 mg/kg/day lowered mean phenylalanine by 236 micromol/L versus a 3 micromol/L rise with placebo; 44% versus 9% had at least a 30% reduction. Model: Randomized human PKU study enriched through prior responsiveness assessment. Limitations: Not all PAH defects respond; trial dose is historical evidence, not individualized guidance. Evidence access: Primary abstract Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17693179/ · DOI 10.1016/S0140-6736(07)61234-3
Complete structured claim and evidenceHuman tyrosine hydroxylase catalyzes BH4-dependent tyrosine hydroxylation to L-DOPA, a downstream step in dopamine biosynthesis.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human TH variant study; established enzyme reaction described in the abstract.
- limitations
- This is a downstream connection, not evidence that oral phenylalanine predictably raises brain dopamine.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- Producing tyrosine is only the first part of the route toward dopamine.
- primary_references
- Tyrosine hydroxylase variants influence protein expression, cellular localization, stability, enzymatic activity and the physical interaction between tyrosine hydroxylase and GTP cyclohydrolase 1. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38084654/ · DOI 10.1002/jimd.12690
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 118–124
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human TH variant study; established enzyme reaction described in the abstract. · source_derived_draft · unverified_draft
## l-phenylalanine-tyrosine-next-step Producing tyrosine is only the first part of the route toward dopamine. Human tyrosine hydroxylase catalyzes BH4-dependent tyrosine hydroxylation to L-DOPA, a downstream step in dopamine biosynthesis. Model: Human TH variant study; established enzyme reaction described in the abstract. Limitations: This is a downstream connection, not evidence that oral phenylalanine predictably raises brain dopamine. Evidence access: Primary abstract Tyrosine hydroxylase variants influence protein expression, cellular localization, stability, enzymatic activity and the physical interaction between tyrosine hydroxylase and GTP cyclohydrolase 1. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38084654/ · DOI 10.1002/jimd.12690
Complete structured claim and evidenceBH4 oxidation accompanied eNOS uncoupling with increased ROS and reduced NO in hypertensive mouse aortas.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/12697739.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d56604695c8c1bda167b76198a472d814d284a3c0c1e1e1eed8943cce31d0ad0", "start_char": 0, "end_char": 1474, "text_sha256": "d56604695c8c1bda167b76198a472d814d284a3c0c1e1e1eed8943cce31d0ad0"}
- experimental_model
- Hypertension and knockout mouse experiments
- exposure
- NADPH-oxidase/NOS genetic comparisons and BH4 treatment
- limitations
- Disease model; the exact response cannot be assumed in people taking citrulline.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Mouse DOCA-salt hypertension model
- plain_language
- Adding precursor is different from fixing a damaged cofactor system.
- primary_references
- [citrulline-p12697739] Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. (2003). https://pubmed.ncbi.nlm.nih.gov/12697739/ DOI: 10.1172/jci14172
- tissue_or_cell_type
- Aortic redox state and NO signaling
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 801–812
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Hypertension and knockout mouse experiments · source_derived_draft · unverified_draft
### citrulline-bh4-oxidation BH4 oxidation accompanied eNOS uncoupling with increased ROS and reduced NO in hypertensive mouse aortas. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Adding precursor is different from fixing a damaged cofactor system. organism: Mouse DOCA-salt hypertension model tissue_or_cell_type: Aortic redox state and NO signaling experimental_model: Hypertension and knockout mouse experiments limitations: Disease model; the exact response cannot be assumed in people taking citrulline. exposure: NADPH-oxidase/NOS genetic comparisons and BH4 treatment evidence_span: {"source_cache": "artifacts/citrulline-research/12697739.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d56604695c8c1bda167b76198a472d814d284a3c0c1e1e1eed8943cce31d0ad0", "start_char": 0, "end_char": 1474, "text_sha256": "d56604695c8c1bda167b76198a472d814d284a3c0c1e1e1eed8943cce31d0ad0"} [citrulline-p12697739] Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. (2003). https://pubmed.ncbi.nlm.nih.gov/12697739/ DOI: 10.1172/jci14172
Complete structured claim and evidenceDHFR knockdown decreased intracellular BH4 and increased BH2 in the cell systems.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/19666465.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af", "start_char": 0, "end_char": 1716, "text_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af"}
- experimental_model
- DHFR knockdown/inhibition and controlled GTPCH-expression cell experiments
- exposure
- Methotrexate or RNA interference; comparison with GTPCH knockdown
- limitations
- Mouse models; DHFR also handles folate, but this study does not make folate and BH4 interchangeable.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Mouse endothelial and NIH-3T3-based experimental cell systems
- plain_language
- Recycling quality matters, not just the total amount of pterin.
- primary_references
- [citrulline-p19666465] Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways. (2009). https://pubmed.ncbi.nlm.nih.gov/19666465/ DOI: 10.1074/jbc.m109.041483
- tissue_or_cell_type
- BH4/BH2 balance and NOS coupling
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 775–786
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · DHFR knockdown/inhibition and controlled GTPCH-expression cell experiments · source_derived_draft · unverified_draft
### citrulline-dhfr-ratio DHFR knockdown decreased intracellular BH4 and increased BH2 in the cell systems. Condition category: machinery_impairment nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Recycling quality matters, not just the total amount of pterin. organism: Mouse endothelial and NIH-3T3-based experimental cell systems tissue_or_cell_type: BH4/BH2 balance and NOS coupling experimental_model: DHFR knockdown/inhibition and controlled GTPCH-expression cell experiments limitations: Mouse models; DHFR also handles folate, but this study does not make folate and BH4 interchangeable. exposure: Methotrexate or RNA interference; comparison with GTPCH knockdown evidence_span: {"source_cache": "artifacts/citrulline-research/19666465.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af", "start_char": 0, "end_char": 1716, "text_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af"} [citrulline-p19666465] Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways. (2009). https://pubmed.ncbi.nlm.nih.gov/19666465/ DOI: 10.1074/jbc.m109.041483
Complete structured claim and evidenceDHFR loss increased eNOS-dependent superoxide while reducing NO production.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/citrulline-research/19666465.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af", "start_char": 0, "end_char": 1716, "text_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af"}
- experimental_model
- DHFR knockdown/inhibition and controlled GTPCH-expression cell experiments
- exposure
- Methotrexate or RNA interference; comparison with GTPCH knockdown
- limitations
- Mouse models; DHFR also handles folate, but this study does not make folate and BH4 interchangeable.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Mouse endothelial and NIH-3T3-based experimental cell systems
- plain_language
- A damaged cofactor balance can change the enzyme output.
- primary_references
- [citrulline-p19666465] Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways. (2009). https://pubmed.ncbi.nlm.nih.gov/19666465/ DOI: 10.1074/jbc.m109.041483
- tissue_or_cell_type
- BH4/BH2 balance and NOS coupling
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 788–799
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · DHFR knockdown/inhibition and controlled GTPCH-expression cell experiments · source_derived_draft · unverified_draft
### citrulline-dhfr-uncoupling DHFR loss increased eNOS-dependent superoxide while reducing NO production. Condition category: machinery_impairment nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A damaged cofactor balance can change the enzyme output. organism: Mouse endothelial and NIH-3T3-based experimental cell systems tissue_or_cell_type: BH4/BH2 balance and NOS coupling experimental_model: DHFR knockdown/inhibition and controlled GTPCH-expression cell experiments limitations: Mouse models; DHFR also handles folate, but this study does not make folate and BH4 interchangeable. exposure: Methotrexate or RNA interference; comparison with GTPCH knockdown evidence_span: {"source_cache": "artifacts/citrulline-research/19666465.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af", "start_char": 0, "end_char": 1716, "text_sha256": "b1ef76ebbd312932011edd1b0f9f428026a4e4cdd53301bd66f99eaf543e77af"} [citrulline-p19666465] Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways. (2009). https://pubmed.ncbi.nlm.nih.gov/19666465/ DOI: 10.1074/jbc.m109.041483
Complete structured claim and evidence5-MTHF increased vascular BH4 and its proportion of total biopterin in human vessel experiments.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/16940192.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b", "start_char": 0, "end_char": 1942, "text_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b"}
- experimental_model
- Ex-vivo vessel exposure and randomized pre-harvest infusion
- exposure
- 5-MTHF ex vivo 1-100 micromolar; intravenous 5-MTHF or placebo in a separate subset
- limitations
- Uses 5-MTHF and acute vessel endpoints; cannot be generalized to all folic-acid doses or combination supplements.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, vessels from 117 CABG patients
- plain_language
- A folate form affected availability of the NO-synthase cofactor.
- primary_references
- [citrulline-p16940192] 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. (2006). https://pubmed.ncbi.nlm.nih.gov/16940192/ DOI: 10.1161/circulationaha.106.612325
- tissue_or_cell_type
- Saphenous veins and internal mammary arteries
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 736–747
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ex-vivo vessel exposure and randomized pre-harvest infusion · source_derived_draft · unverified_draft
### citrulline-folate-bh4 5-MTHF increased vascular BH4 and its proportion of total biopterin in human vessel experiments. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A folate form affected availability of the NO-synthase cofactor. organism: Human, vessels from 117 CABG patients tissue_or_cell_type: Saphenous veins and internal mammary arteries experimental_model: Ex-vivo vessel exposure and randomized pre-harvest infusion limitations: Uses 5-MTHF and acute vessel endpoints; cannot be generalized to all folic-acid doses or combination supplements. exposure: 5-MTHF ex vivo 1-100 micromolar; intravenous 5-MTHF or placebo in a separate subset evidence_span: {"source_cache": "artifacts/citrulline-research/16940192.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b", "start_char": 0, "end_char": 1942, "text_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b"} [citrulline-p16940192] 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. (2006). https://pubmed.ncbi.nlm.nih.gov/16940192/ DOI: 10.1161/circulationaha.106.612325
Complete structured claim and evidence5-MTHF improved eNOS coupling and increased its dimer-to-monomer ratio and activity in the human vessel study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/16940192.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b", "start_char": 0, "end_char": 1942, "text_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b"}
- experimental_model
- Ex-vivo vessel exposure and randomized pre-harvest infusion
- exposure
- 5-MTHF ex vivo 1-100 micromolar; intravenous 5-MTHF or placebo in a separate subset
- limitations
- Uses 5-MTHF and acute vessel endpoints; cannot be generalized to all folic-acid doses or combination supplements.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, vessels from 117 CABG patients
- plain_language
- The enzyme used its electron supply more productively under the tested conditions.
- primary_references
- [citrulline-p16940192] 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. (2006). https://pubmed.ncbi.nlm.nih.gov/16940192/ DOI: 10.1161/circulationaha.106.612325
- tissue_or_cell_type
- Saphenous veins and internal mammary arteries
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 749–760
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ex-vivo vessel exposure and randomized pre-harvest infusion · source_derived_draft · unverified_draft
### citrulline-folate-coupling 5-MTHF improved eNOS coupling and increased its dimer-to-monomer ratio and activity in the human vessel study. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The enzyme used its electron supply more productively under the tested conditions. organism: Human, vessels from 117 CABG patients tissue_or_cell_type: Saphenous veins and internal mammary arteries experimental_model: Ex-vivo vessel exposure and randomized pre-harvest infusion limitations: Uses 5-MTHF and acute vessel endpoints; cannot be generalized to all folic-acid doses or combination supplements. exposure: 5-MTHF ex vivo 1-100 micromolar; intravenous 5-MTHF or placebo in a separate subset evidence_span: {"source_cache": "artifacts/citrulline-research/16940192.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b", "start_char": 0, "end_char": 1942, "text_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b"} [citrulline-p16940192] 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. (2006). https://pubmed.ncbi.nlm.nih.gov/16940192/ DOI: 10.1161/circulationaha.106.612325
Complete structured claim and evidence5-MTHF reduced vascular superoxide; the effect was not explained by direct superoxide scavenging or changed plasma homocysteine.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/16940192.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b", "start_char": 0, "end_char": 1942, "text_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b"}
- experimental_model
- Ex-vivo vessel exposure and randomized pre-harvest infusion
- exposure
- 5-MTHF ex vivo 1-100 micromolar; intravenous 5-MTHF or placebo in a separate subset
- limitations
- Uses 5-MTHF and acute vessel endpoints; cannot be generalized to all folic-acid doses or combination supplements.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, vessels from 117 CABG patients
- plain_language
- The experiment distinguished this effect from simply lowering homocysteine.
- primary_references
- [citrulline-p16940192] 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. (2006). https://pubmed.ncbi.nlm.nih.gov/16940192/ DOI: 10.1161/circulationaha.106.612325
- tissue_or_cell_type
- Saphenous veins and internal mammary arteries
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 762–773
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ex-vivo vessel exposure and randomized pre-harvest infusion · source_derived_draft · unverified_draft
### citrulline-folate-superoxide 5-MTHF reduced vascular superoxide; the effect was not explained by direct superoxide scavenging or changed plasma homocysteine. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The experiment distinguished this effect from simply lowering homocysteine. organism: Human, vessels from 117 CABG patients tissue_or_cell_type: Saphenous veins and internal mammary arteries experimental_model: Ex-vivo vessel exposure and randomized pre-harvest infusion limitations: Uses 5-MTHF and acute vessel endpoints; cannot be generalized to all folic-acid doses or combination supplements. exposure: 5-MTHF ex vivo 1-100 micromolar; intravenous 5-MTHF or placebo in a separate subset evidence_span: {"source_cache": "artifacts/citrulline-research/16940192.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b", "start_char": 0, "end_char": 1942, "text_sha256": "42c07dd0bbacfc1ff44f78d6ce69810a58946e53c76bf5d3bf8385db5278ba8b"} [citrulline-p16940192] 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. (2006). https://pubmed.ncbi.nlm.nih.gov/16940192/ DOI: 10.1161/circulationaha.106.612325
Complete structured claim and evidenceThe NOS2 zinc-tetrathiolate center supported intersubunit contacts and integrity of the BH4-binding site.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10409685.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c320fb6f3fd659a2e7df4a8ddd3467a902a07b84380075d429040eaf244ccf6b", "start_char": 0, "end_char": 942, "text_sha256": "c320fb6f3fd659a2e7df4a8ddd3467a902a07b84380075d429040eaf244ccf6b"}
- experimental_model
- Crystal structures of zinc-free and zinc-bound heme domains
- exposure
- Zinc-free versus zinc-tetrathiolate-containing structures
- limitations
- Direct structure is NOS2; similarity to NOS3 does not justify silently treating the proteins as identical.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human NOS2
- plain_language
- The structural metal and the pterin-binding region are connected.
- primary_references
- [citrulline-p10409685] Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. (1999). https://pubmed.ncbi.nlm.nih.gov/10409685/ DOI: 10.1074/jbc.274.30.21276
- tissue_or_cell_type
- NOS dimer interface and pterin-binding region
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 606–617
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crystal structures of zinc-free and zinc-bound heme domains · source_derived_draft · unverified_draft
### citrulline-inos-zinc-interface The NOS2 zinc-tetrathiolate center supported intersubunit contacts and integrity of the BH4-binding site. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The structural metal and the pterin-binding region are connected. organism: Human NOS2 tissue_or_cell_type: NOS dimer interface and pterin-binding region experimental_model: Crystal structures of zinc-free and zinc-bound heme domains limitations: Direct structure is NOS2; similarity to NOS3 does not justify silently treating the proteins as identical. exposure: Zinc-free versus zinc-tetrathiolate-containing structures evidence_span: {"source_cache": "artifacts/citrulline-research/10409685.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c320fb6f3fd659a2e7df4a8ddd3467a902a07b84380075d429040eaf244ccf6b", "start_char": 0, "end_char": 942, "text_sha256": "c320fb6f3fd659a2e7df4a8ddd3467a902a07b84380075d429040eaf244ccf6b"} [citrulline-p10409685] Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. (1999). https://pubmed.ncbi.nlm.nih.gov/10409685/ DOI: 10.1074/jbc.274.30.21276
Complete structured claim and evidenceAdding BH4 increased the reported walking-distance change to 28.15% only in the subgroup with baseline ADMA above 0.4 micromolar.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"}
- experimental_model
- Phase II double-blind placebo-controlled crossover trial
- exposure
- 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm
- limitations
- Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 51 peripheral-artery-disease patients
- plain_language
- The cofactor combination result depended on the measured starting state.
- primary_references
- [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
- tissue_or_cell_type
- Absolute claudication distance and plasma biomarkers
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1217–1228
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Phase II double-blind placebo-controlled crossover trial · source_derived_draft · unverified_draft
### citrulline-pad-bh4-subgroup Adding BH4 increased the reported walking-distance change to 28.15% only in the subgroup with baseline ADMA above 0.4 micromolar. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cofactor combination result depended on the measured starting state. organism: Human, 51 peripheral-artery-disease patients tissue_or_cell_type: Absolute claudication distance and plasma biomarkers experimental_model: Phase II double-blind placebo-controlled crossover trial limitations: Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription. exposure: 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm evidence_span: {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"} [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
Complete structured claim and evidenceWalking-distance change was 20.11% with citrulline versus 5.73% with placebo, P=0.011.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"}
- experimental_model
- Phase II double-blind placebo-controlled crossover trial
- exposure
- 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm
- limitations
- Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Human, 51 peripheral-artery-disease patients
- plain_language
- A patient-relevant walking endpoint improved in this preliminary PAD trial.
- primary_references
- [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
- tissue_or_cell_type
- Absolute claudication distance and plasma biomarkers
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 1204–1215
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Phase II double-blind placebo-controlled crossover trial · source_derived_draft · unverified_draft
### citrulline-pad-walking Walking-distance change was 20.11% with citrulline versus 5.73% with placebo, P=0.011. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A patient-relevant walking endpoint improved in this preliminary PAD trial. organism: Human, 51 peripheral-artery-disease patients tissue_or_cell_type: Absolute claudication distance and plasma biomarkers experimental_model: Phase II double-blind placebo-controlled crossover trial limitations: Preliminary trial; subgroup-dependent BH4 result and study-specific ADMA cutoff require confirmation; not a general supplement prescription. exposure: 3 g citrulline twice daily for 12 weeks; additional BH4 0.45 g/day for two weeks in one arm evidence_span: {"source_cache": "artifacts/citrulline-research/39985883.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c", "start_char": 0, "end_char": 1888, "text_sha256": "0007fe7b3fcc746e77c450f3aca50ca2834c78b84aa83977b3078ae05051ab9c"} [citrulline-p39985883] Nutritional L-Citrulline and Tetrahydrobiopterin in Peripheral Artery Disease: A Phase II Randomized Trial (CIPER Study). (2025). https://pubmed.ncbi.nlm.nih.gov/39985883/ DOI: 10.1016/j.jacadv.2025.101590
Complete structured claim and evidenceCombination treatment improved eNOS dimer ratios and NO production more than either single intervention.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"}
- experimental_model
- Controlled neonatal hypoxia and combination-treatment experiment
- exposure
- L-citrulline, sapropterin, or both during days 3-10 of hypoxia
- limitations
- Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Newborn pig
- plain_language
- The measured signaling machinery responded alongside the vascular outcome.
- primary_references
- [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
- tissue_or_cell_type
- Pulmonary arteries and hemodynamics
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 827–838
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled neonatal hypoxia and combination-treatment experiment · source_derived_draft · unverified_draft
### citrulline-pig-combination-coupling Combination treatment improved eNOS dimer ratios and NO production more than either single intervention. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The measured signaling machinery responded alongside the vascular outcome. organism: Newborn pig tissue_or_cell_type: Pulmonary arteries and hemodynamics experimental_model: Controlled neonatal hypoxia and combination-treatment experiment limitations: Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans. exposure: L-citrulline, sapropterin, or both during days 3-10 of hypoxia evidence_span: {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"} [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
Complete structured claim and evidenceCombined citrulline and BH4 improved pulmonary vascular resistance more than either alone in hypoxic piglets.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"}
- experimental_model
- Controlled neonatal hypoxia and combination-treatment experiment
- exposure
- L-citrulline, sapropterin, or both during days 3-10 of hypoxia
- limitations
- Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Newborn pig
- plain_language
- Both substrate supply and cofactor support mattered in this animal model.
- primary_references
- [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
- tissue_or_cell_type
- Pulmonary arteries and hemodynamics
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 814–825
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled neonatal hypoxia and combination-treatment experiment · source_derived_draft · unverified_draft
### citrulline-pig-combination-pvr Combined citrulline and BH4 improved pulmonary vascular resistance more than either alone in hypoxic piglets. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Both substrate supply and cofactor support mattered in this animal model. organism: Newborn pig tissue_or_cell_type: Pulmonary arteries and hemodynamics experimental_model: Controlled neonatal hypoxia and combination-treatment experiment limitations: Animal combination evidence; does not establish neonatal clinical dosing or treatment benefit in humans. exposure: L-citrulline, sapropterin, or both during days 3-10 of hypoxia evidence_span: {"source_cache": "artifacts/citrulline-research/32073878.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f", "start_char": 0, "end_char": 1850, "text_sha256": "3362b0aae303b9c2e54cfa8a291e4d993ab4496d26cf11a1dba96c27c4c3fb7f"} [citrulline-p32073878] Combined l-citrulline and tetrahydrobiopterin therapy improves NO signaling and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. (2020). https://pubmed.ncbi.nlm.nih.gov/32073878/ DOI: 10.1152/ajplung.00280.2019
Complete structured claim and evidenceAscorbate increased intracellular BH4 in porcine aortic endothelial cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"}
- experimental_model
- Cell exposure and recombinant-enzyme assays
- exposure
- Ascorbate loading; BH4 or sepiapterin comparisons
- limitations
- Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Porcine aortic endothelial cells and bovine eNOS
- plain_language
- Vitamin C can affect cofactor availability in this cell model.
- primary_references
- [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
- tissue_or_cell_type
- BH4 availability and NO bioactivity
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 697–708
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell exposure and recombinant-enzyme assays · source_derived_draft · unverified_draft
### citrulline-vitaminc-bh4 Ascorbate increased intracellular BH4 in porcine aortic endothelial cells. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin C can affect cofactor availability in this cell model. organism: Porcine aortic endothelial cells and bovine eNOS tissue_or_cell_type: BH4 availability and NO bioactivity experimental_model: Cell exposure and recombinant-enzyme assays limitations: Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline. exposure: Ascorbate loading; BH4 or sepiapterin comparisons evidence_span: {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"} [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
Complete structured claim and evidenceAscorbate increased arginine-to-citrulline conversion and NO-related output in porcine endothelial cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"}
- experimental_model
- Cell exposure and recombinant-enzyme assays
- exposure
- Ascorbate loading; BH4 or sepiapterin comparisons
- limitations
- Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline.
- nutrient_topic
- Citrulline research collection; topical membership is not evidence of a direct dietary effect. · L-Citrulline
- organism
- Porcine aortic endothelial cells and bovine eNOS
- plain_language
- Protecting the machinery can matter as well as supplying arginine.
- primary_references
- [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
- tissue_or_cell_type
- BH4 availability and NO bioactivity
Citrulline: arginine recycling, nitrogen disposal and nutrient connections (2026-09-17) · lines 710–721
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell exposure and recombinant-enzyme assays · source_derived_draft · unverified_draft
### citrulline-vitaminc-no Ascorbate increased arginine-to-citrulline conversion and NO-related output in porcine endothelial cells. Condition category: normal nutrient_topic: Citrulline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Protecting the machinery can matter as well as supplying arginine. organism: Porcine aortic endothelial cells and bovine eNOS tissue_or_cell_type: BH4 availability and NO bioactivity experimental_model: Cell exposure and recombinant-enzyme assays limitations: Preclinical experiments; not proof that vitamin C is needed as a co-supplement with citrulline. exposure: Ascorbate loading; BH4 or sepiapterin comparisons evidence_span: {"source_cache": "artifacts/citrulline-research/10749876.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed", "start_char": 0, "end_char": 1519, "text_sha256": "10605941fa542bd62ed4ee0fb042ea7569f3ab619f1cb893b54d7e62386712ed"} [citrulline-p10749876] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. (2000). https://pubmed.ncbi.nlm.nih.gov/10749876/ DOI: 10.1074/jbc.m002248200
Complete structured claim and evidenceTyrosine hydroxylase is a non-heme iron enzyme that uses molecular oxygen to hydroxylate tyrosine to L-DOPA and tetrahydrobiopterin to 4a-hydroxybiopterin in the rate-limiting step of the catecholamine biosynthetic pathway.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/cold-research/9753429.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9", "start_char": 0, "end_char": 1695, "text_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9"}
- experimental_model
- Crystal structure of rat tyrosine hydroxylase with a cofactor analogue and iron at 2.3 angstrom
- exposure
- Bound 7,8-dihydrobiopterin and iron
- limitations
- Structural chemistry of the rate-limiting step. It is a rat enzyme structure with a cofactor analogue, not a measurement of iron status in an animal.
- nutrient_topic
- Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. · Cold water immersion
- organism
- Rat enzyme
- plain_language
- The first and slowest step of making noradrenaline needs an iron atom and a molecule of oxygen.
- primary_references
- [cold-p9753429] Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site. (1998). https://pubmed.ncbi.nlm.nih.gov/9753429/ DOI: 10.1021/bi981462g
- tissue_or_cell_type
- Purified catalytic and tetramerization domains
Cold water immersion: cold sensing, heat production, the catecholamine axis and what repeated exposure changes (2026-09-19) · lines 533–544
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Crystal structure of rat tyrosine hydroxylase with a cofactor analogue and iron at 2.3 angstrom · source_derived_draft · unverified_draft
### cold-th-iron-oxygen-pterin Tyrosine hydroxylase is a non-heme iron enzyme that uses molecular oxygen to hydroxylate tyrosine to L-DOPA and tetrahydrobiopterin to 4a-hydroxybiopterin in the rate-limiting step of the catecholamine biosynthetic pathway. Condition category: normal nutrient_topic: Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. plain_language: The first and slowest step of making noradrenaline needs an iron atom and a molecule of oxygen. organism: Rat enzyme tissue_or_cell_type: Purified catalytic and tetramerization domains experimental_model: Crystal structure of rat tyrosine hydroxylase with a cofactor analogue and iron at 2.3 angstrom limitations: Structural chemistry of the rate-limiting step. It is a rat enzyme structure with a cofactor analogue, not a measurement of iron status in an animal. exposure: Bound 7,8-dihydrobiopterin and iron evidence_span: {"source_cache": "artifacts/cold-research/9753429.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9", "start_char": 0, "end_char": 1695, "text_sha256": "3c76ec6d5dadb463c0a044175d5a78fbd02df4da7c339029c8c232e8878175b9"} [cold-p9753429] Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site. (1998). https://pubmed.ncbi.nlm.nih.gov/9753429/ DOI: 10.1021/bi981462g
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.